Built for the people who own aesthetic practices.
Inside MedSpa is an independent trade publication for medspa and aesthetic-practice owners — not patients, not vendors, not the consumer beauty press. We cover what changes the business: FDA decisions and recalls, the companies you buy from, and the rules you operate under.
How we pick what matters
There's no shortage of noise in medical aesthetics: press releases, sponsored "education", consumer listicles. Most of it isn't written for the person who runs the practice. We cut hard against three filters, and an item has to clear at least one:
Your money. Product pricing and supply, rebate and loyalty programs, and the moves of the companies you buy from.
Your license. FDA actions, recalls, and the rules that govern who can do what in your practice.
Your patients' demand. New products and approvals that change what patients come in asking for.
If an item doesn't change a decision an owner makes about pricing, compliance, hiring, purchasing, or positioning, it doesn't run. Generic "5 marketing tips" is exactly what we leave out.
The primary sources we monitor
From September 2026, every new article starts from a primary document, the record itself rather than someone else's write-up of it:
- FDA — 510(k) clearances, PMA and drug or biologic approvals, recalls, safety communications and warning letters, from the FDA's own databases.
- SEC EDGAR — filings from the public companies that make and sell aesthetic products and devices.
- The Federal Register — proposed and final federal rules that touch aesthetic practices and the products they use.
- Public market data — prices and corporate events for the public companies in the field, used in our trackers.
Our role is judgment: we read the firehose so you don't, and hand you only the few things that actually changed something — with the context to know what to do.
Independent by design
Most trade coverage in medical aesthetics is published by companies that sell something to practices — devices, software, financing — and their content has to end in a demo. We sell none of those things. Inside MedSpa is supported by advertising, and no company pays to be covered. Sponsored placements, if we ever run them, will be clearly labeled and won't shape what we cover.
How it's made
Inside MedSpa is produced with AI. A system we built for this field drafts each article from the source documents above, and automated checks hold drafts that repeat a story we've already covered or that describe future events as if they'd happened. Those checks are software, not a clinician or a lawyer, and they miss things, so we publish corrections in the open. Many articles in our archive from before September 2026 were drafted from news reports rather than primary documents; we're reviewing them and correcting, consolidating or removing the ones that don't meet our editorial policy.
Who's behind it
Edited by Evan — more about Evan and how the brief gets made →
Accuracy & corrections
We aim to be accurate first. New articles link the document they're based on, so you can check it yourself. We're a business publication, not your lawyer or clinician: confirm regulatory specifics with FDA.gov, your state board or your counsel before you act. Spot something wrong? Tell us, and see our corrections log.
Read our editorial policy and our corrections log.
You can also reach us directly at contact@quillandharbor.com.
Get the free brief Read a sample first →
Inside MedSpa is a general, impersonal publication for medical-aesthetics business owners. It is not individualized business, financial, medical, or legal advice. Any market or company information is general in nature and not a recommendation.